Jim Cramer Believes Lawsuits Are No Longer a Major Threat to Johnson & Johnson

Group 1 - Johnson & Johnson is focusing on innovative cancer drugs and medical devices, particularly in cardiovascular care, as highlighted by CEO Joaquin Duato [1][2] - The company is currently facing talc lawsuits, but there is a belief that the risk from asbestos and baby powder litigation has peaked, with J&J winning several cases [1] - J&J plans to continue fighting the lawsuits individually, with expectations that plaintiffs may eventually find it too costly to pursue [1] Group 2 - Johnson & Johnson develops a wide range of pharmaceuticals and medical technologies, including areas such as immunology, oncology, and cardiovascular care [2]